2026 ICD-10-CM Diagnosis Code D68.69Other thrombophilia

ICD-10-CM Codes›D50–D89›D65-D69›D68

ICD-10-CM D68.69
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

D68.69 is a billable ICD-10-CM diagnosis code for other thrombophilia. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 814 through 816. As a secondary diagnosis, it counts as a complication or comorbidity (CC) and moves an inpatient stay to a higher severity level within its MS-DRG family. It does not count, however, when the principal diagnosis is one of 42 closely related codes. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Coagulation and hemorrhagic disorders.

D68.69 no longer risk-adjusts for Medicare Advantage: it mapped to HCC 48 under the retired CMS-HCC V24 model through payment year 2025 but maps to no category in the live V28 model. It still risk-adjusts in the PACE (CMS-HCC V22) category 48, ESRD (V21) category 48, and ESRD (V24) category 48 for payment year 2026.

Code Identity

ICD-10-CM Code
D68.69
Billable Status
Yes — Valid for Submission
Code Describes
Other thrombophilia
Short Description
Other thrombophilia
Same as the full description in the CMS dataset.
Parent Code
Other thrombophilia

Code Classification

ChapterD50–D89Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
SectionD65-D69Coagulation defects, purpura and other hemorrhagic conditions
CategoryD68Other coagulation defects
This CodeD68.69Other thrombophilia

Medicare Risk Adjustment (HCC)Billing

D68.69 no longer risk-adjusts for Medicare Advantage: it maps to no payment category in the live CMS-HCC V28 model, although it still risk-adjusts in the other CMS models shown below.

CMS-HCC V28 (Medicare Advantage Payment Model)
Not mapped
Dropped in V28 see all codes that no longer risk-adjust
Prior Model (CMS-HCC V24)
HCC 48
V24 retired last contributed to a Medicare Advantage risk score in payment year 2025
Other CMS Models
PACE (CMS-HCC V22): HCC 48 · ESRD (V21): HCC 48 · ESRD (V24): HCC 48
ESRD V21 weights: 0.059 dialysis, 0.173–0.234 functioning graft · ESRD V24 weights: 0.063 dialysis, 0.192–0.358 functioning graft
Part D (RxHCC)
Not mapped
D68.69 does not risk-adjust in the RxHCC prescription drug model

Source: CMS Payment Year 2026 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Acquired thrombophilia
  • Hypercoagulability state
  • Hypercoagulable state due to atrial fibrillation
  • Secondary hypercoagulability state
  • Thrombophilia associated with pregnancy
  • Thrombophilia caused by vascular device
  • Thrombophilia due to antineoplastic agent therapy
  • Thrombophilia due to hormone therapy
  • Thrombophilia due to immobilization
  • Thrombophilia due to malignant neoplasm
  • Thrombophilia due to myeloproliferative disorder
  • Thrombophilia due to paroxysmal nocturnal hemoglobinuria
  • Thrombophilia due to trauma
  • Thrombophilia due to vascular anomaly

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • COVID-19 associated hypercoagulability
  • Hypercoagulable states NEC
  • Secondary hypercoagulable state NOS

Code Also

  • , if applicable, associated condition

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR BLD006
Coagulation and hemorrhagic disorders
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Thrombophilia

    a disorder of hemostasis in which there is a tendency for the occurrence of thrombosis.

Patient EducationClinical

Bleeding Disorders

Normally, if you get hurt, your body forms a blood clot to stop the bleeding. For blood to clot, your body needs cells called platelets and proteins known as clotting factors. If you have a bleeding disorder, you either do not have enough platelets or clotting factors or they don't work the way they should.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert D68.69 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
289.82 Sec hypercoagulable st
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About D68.69Overview

What is the ICD-10 code for other thrombophilia?

The ICD-10-CM code for other thrombophilia is D68.69 (sometimes written as D6869). It is billable on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

Is D68.69 (Other thrombophilia) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report other thrombophilia on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does D68.69 group to?

When other thrombophilia is the principal diagnosis on an inpatient stay, it groups to MS-DRG 814, 815, 816, with relative weights from 0.6320 to 2.1267 depending on complications. Higher weights mean higher Medicare reimbursement.

Is D68.69 a CC or MCC?

CMS lists D68.69 as a CC (complication or comorbidity) for FY 2026. Reported as a secondary diagnosis, it moves the inpatient stay to a higher-weighted DRG within its severity family. It does not count when the principal diagnosis is one of the 42 closely related codes in its exclusion list.

What is the ICD-9 equivalent of D68.69?

Under the General Equivalence Mappings, other thrombophilia converts to ICD-9-CM 289.82 (sec hypercoagulable st). The mapping is approximate, so confirm the match fits the documentation.

Does D68.69 risk-adjust for Medicare Advantage payment?

Not for Medicare Advantage. D68.69 mapped to HCC 48 in the retired CMS-HCC V24 model, which last determined payment in 2025, but it maps to no category in the live V28 model; see all codes that no longer risk-adjust. It still risk-adjusts in the PACE (CMS-HCC V22) category 48 (Coagulation Defects and Other Specified Hematological Disorders), ESRD (V21) category 48 (Coagulation Defects and Other Specified Hematological Disorders), and ESRD (V24) category 48 (Coagulation Defects and Other Specified Hematological Disorders).